GlassScriptPhysician profile
Richard M Todd
NPI 1427274455
$3,146.23
in general payments reported to CMS, 2019-2025
20 companies · $761 in 2025
The $761 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $675 · 2022: $326 · 2023: $681 · 2024: $703 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,145.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,423.45 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $599.65 | 2021-2025 | |
| Shockwave Medical, INC | $314.83 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $132.78 | 2023-2025 | |
| Astellas Pharma US INC | $125.81 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $124.18 | 2023-2025 | Airsupra, Breztri |
| Dexcom, INC. | $54.74 | 2021-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $44.81 | 2021 | |
| Tactile Systems Technology INC | $41.37 | 2023 | Flexitouch Plus, Entre Plus |
| Exact Sciences Corporation | $38.67 | 2025 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $37.42 | 2025 | Qelbree |
| Ascensia Diabetes Care US INC. | $32.46 | 2023 | |
| Biogen, INC. | $28.66 | 2021 | |
| Amgen INC. | $24.23 | 2024 | Otezla, Repatha |
| Abbott Laboratories | $23.94 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $22.12 | 2024 | Ycanth |
| Tolmar, INC. | $21.01 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.90 | 2022 | |
| Ironshore Pharmaceuticals INC. | $19.76 | 2024 | |
| Glaxosmithkline, LLC. | $15.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.